共 50 条
- [41] Non-HDL-Cholesterol Is a Simple and Useful Predictor of Cardiovascular Complications in Japanese Patients with Type 2 Diabetes. The Japan Diabetes Complications Study (JDCS)DIABETES, 2009, 58 : A191 - A191Sone, HirohitoTanaka, SachikoIimuro, SatoshiTanaka, ShiroOida, KojiYamasaki, YoshimitsuOikawa, ShinichiIshibashi, ShunKatayama, ShigehiroIto, HidekiOhashi, YasuoAkanuma, YasuoYamada, Nobuhiro
- [42] ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic womenENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (08): : 502 - 511Lizet Reynoso-Villalpando, GabrielaSevillano-Collantes, CristinaValle, YeminiaMoreno-Ruiz, InmaculadaRamon Padilla-Gutierrez, JorgeJavier del Canizo-Gomez, Francisco
- [43] Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM studyATHEROSCLEROSIS, 2011, 217 (01) : 263 - 267Brouwers, M. C. G. J.Troutt, J. S.van Greevenbroek, M. M. J.Ferreira, I.Feskens, E. J.van der Kallen, C. J. H.Schaper, N. C.Schalkwijk, C. G.Konrad, R. J.Stehouwer, C. D. A.
- [44] The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato StudyPLOS ONE, 2014, 9 (05):Bruno, GraziellaBarutta, FedericaLandi, AndreaPerin, Paolo CavalloGruden, Gabriella
- [45] Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular diseasePHARMACOLOGICAL RESEARCH, 2005, 51 (01) : 31 - 36Smahelová, AHyspler, RHaas, TTichá, ABláha, VZadák, Z
- [46] N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes: The Casale Monferrato population-based studyDIABETES CARE, 2013, 36 (09) : 2677 - 2682Bruno, GraziellaLandi, AndreaBarutta, FedericaGhezzo, GiuseppeBaldin, ClaudioSpadafora, LauraSchimmenti, AndreaPrinzis, TaniaPerin, Paolo CavalloGruden, Gabriella
- [47] Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targetsBIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (01): : 89 - 94Kappelle, Paul J. W. H.Dallinga-Thie, Geesje M.Dullaart, Robin P. F.
- [48] Low-Density Lipoprotein Particle Number (LDL-P) Distribution in Type 2 Diabetes Who Have Achieved Low Concentrations of Non-HDL Cholesterol (non-HDL-C <80 mg/dL)CIRCULATION, 2011, 124 (21)Malave, Hector A.Pourfarzib, RayMurthy, Thippeswamy H.Burkle, JamieCastro, Manuel E.
- [49] The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2Cardiovascular Diabetology, 23 (1)Timothy M. E. DavisS. A. Paul ChubbWendy A. Davis
- [50] The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: a population-based retrospective cohort studyBMC Medicine, 22 (1)David Tak Wai LuiLanlan LiXiaodong LiuXi XiongEric Ho Man TangChi Ho LeeYu Cho WooBrian Hung Hin LangCarlos King Ho WongKathryn Choon Beng Tan